iRhythm Investors Who Have Suffered Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC) to determine whether the Company engaged in securities fraud or other unlawful business practices.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, iRHYTHM SECURITIES BETWEEN AUGUST 4, 2020 AND JANUARY 28, 2021, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”), AND SUFFERED LOSSES GREATER THAN $100,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, BUSINESS DEVELOPMENT, (215) 792-6676, EXT. 802, [email protected], [email protected], [email protected], TO DISCUSS THE SECURITIES INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
On February 1, 2021, a class action lawsuit was filed against iRhythm in United States District Court, Northern District of California.
According to the class action complaint, throughout the Class Period, the iRhythm Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts to investors. The iRhythm Defendants, allegedly, misrepresented and/or failed to disclose to investors that (1) iRhythm’s business would suffer as a result of the U.S. Centers for Medicare and Medicaid Services’ (“CMS”) rulemaking; (2) reimbursement rates would in fact plummet; (3) a lack of national pricing in the CMS rule and fee schedule would cause uncertainty and weakness in the Company’s business; and (4) as a result of the foregoing, the iRhythm Defendants’ public statements were materially false and misleading at all relevant times.